Geneva, Switzerland – October 13, 2023 – The World Health Organization (WHO) successfully concluded the 57th Meeting of the Expert Committee on Specifications for Pharmaceutical Preparations.

Held at the WHO headquarters, the five-day event, spanning from October 9 to 13, saw a congregation of experts from all WHO Regions, including Natalia Volovyk, Deputy Director for Quality at the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines, who represented the State Pharmacopoeia of Ukraine.

The committee delved into an array of pivotal topics, marking significant strides towards enhanced pharmaceutical quality and safety. Analytical tests for DEG/EG in liquid oral dosage forms, new monographs on COVID-19 therapeutics, GMP for excipients, good laboratory practices for pharmaceutical quality control laboratories, WHO Biowaiver list and guidelines on bioanalytical method validation and study sample analysis were at the forefront of the discussions. Every discussion, insight, and decision emanated from the meeting is poised to shape the future of pharmaceutical preparations globally.

The 57th meeting epitomized international collaboration and expertise, reinforcing the path towards a world where quality pharmaceuticals are accessible and reliable.

Experts from all WHO Regions converged in pursuit of elevating pharmaceutical standards globally.


Natalia Volovyk, representative of the State Pharmacopoeia of Ukraine (SPhU).


Natalia Volovyk (SPhU) with Petra Doerr, Director of EDQM.


Natalia Volovyk (SPhU) with Herbert Schmidt (WHO).